Medicare Reimbursement for MyProstateScore 2.0 is Now Available!
Learn More
Skip to content
Lynx Dx Logo
  • Providers
  • Patients
  • About Us
    • Leadership
  • Billing
  • Resources
  • Contact
MyProstateScore 2.0

Next Generation of Prostate Cancer Risk Screening

You deserve the most comprehensive and clinically flexible tool for prostate cancer risk prediction. MPS2 is optimized for unrivaled accuracy for both previously negative biopsy and biopsy naïve patients, offering clear insights and certainty for peace of mind.

I am a Provider
I am a Patient
LynxDx

Lynx Dx provides best-in-class diagnostic testing services to help people live healthy and productive lives.

Read More
CAP Accredited - College of American Pathologists

Lynx Dx

  • About Us
  • Resources
  • Careers
  • Licensure
  • Contact Us

Product

  • MyProstateScore 2.0
  • For Patients
  • For Providers
  • Billing
© Lynx Dx  |  Terms & Conditions  |  HIPAA  |  Privacy Policy  |  Cookie List  |  Cookie Policy
Page load link